Abstract
BACKGROUND. Canine prostate cancer (PCa) is an excellent preclinical model for human PCa. AR-42 is a histone deacetylase inhibitor (HDACi) developed a......
小提示:本篇文献需要登录阅读全文,点击跳转登录